
Sulfonamides and Derivatives
Found 2592 products of "Sulfonamides and Derivatives"
N-Nitroso rac Bendroflumethiazide
Controlled ProductFormula:C15H13F3N4O5S2Color and Shape:NeatMolecular weight:450.413Indomethacin 1-Menthol ester
CAS:Controlled ProductApplications Indomethacin terpenoids' esters were synthesized and assessed both in vitro and in vivo as indomethacin dermal prodrugs.
References Bonina,, Francesco. , et al.: European Journal of Pharmaceutical Sciences, 14, 123 (2001),Formula:C29H34ClNO4Color and Shape:NeatMolecular weight:496.038trans-Carboxy Glimepiride-d5
CAS:Controlled ProductApplications An active labelled metabolite of Glimepiride (G410150).
References Groop, L., et al.: Diabetes Care, 15, 737 (1992), Muller, G., et al.: Diabetes, 42, 1852 (1993), Kramer, W., et al.: Biochem. Biophys. Acta, 119, 278 (1994),Formula:C24H27D5N4O7SColor and Shape:NeatMolecular weight:525.633-[(4-Aminophenyl)sulfonyl]benzenamine
CAS:Controlled ProductApplications 3-[(4-Aminophenyl)sulfonyl]benzenamine is an impurity of Dapsone (D193250), an antibacterial used in the treatment of dermatitis herpetiformis.
References Francis, J., et al.: Br. J. Pharmacol., 5, 565 (1950); Uetrecht, J., et al.: Clin. Dermatol., 7, 111 (1989); Reszka, K., et al.: Chem. Res. Toxicol., 22, 1137 (2009); Santos, J., et al.: Bioorg. Med. Chem., 17, 3795 (2009);Varma, M., et al.: J. Med. Chem., 52, 4844 (2009)Formula:C12H12N2O2SColor and Shape:NeatMolecular weight:248.301N-Acetylsulfathiazole-d4 (Major)
CAS:Controlled ProductApplications A deuterated metabolite of the drug Sulfathiazole.
Formula:C112H4H7N3O3S2Color and Shape:NeatMolecular weight:301.383-Azabicyclo[3.3.0]octane Hydrochloride
CAS:Controlled ProductApplications 3-Azabicyclo[3.3.0]octane Hydrochloride is a reactant in the preparation of substituted pyrimidines derivatives as novel hedgehog signaling pathway inhibitors.
References Xin, M. et al.: Med. Chem. Res., 23, 3784 (2014); Xin, M. et al.: Bioorg. Med. Chem. Lett., 24, 983 (2014);Formula:C7H13N·ClHColor and Shape:White To Light YellowMolecular weight:147.658-Isopropyl Etodolac
CAS:Controlled ProductImpurity Etodolac EP Impurity D
Applications 8-Isopropyl Etodolac (Etodolac EP Impurity D) is an impurity in the synthesis of Etodolac (E933100), may have use in the treatment of myeloma. COX-1/COX-2/β-catenin inhibitors, or anti-inflammatory agent.
References Humber, L.G., et al.: Med. Res. Rev., 7, 1 (1987); Balfour, J.A, et al.: Drugs, 42, 274 (1991); Kato, et al.: J. Pharm. Pharmacol., 53 1679 (2001);Formula:C18H23NO3Color and Shape:NeatMolecular weight:301.38N-Acetyl Sulfadiazine-d4 (Major)
CAS:Controlled ProductApplications A major labelled metabolite of Sulfadiazine.
References Woolley, J., et al.: Drug Metab. Dispos., 7, 94 (1979), Nielsen, P., et al.: Biochem. Pharmacol., 35, 2509 (1986), Anari, M., et al.: Anal. Chem., 76, 823 (2004), Edlund, P., et al.: J. Pharm. Biomed. Anal., 34, 1079 (2004),Formula:C12H8D4N4O3SColor and Shape:NeatMolecular weight:296.34(4R,6S)-5,6-Dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol 7,7-Dioxide
CAS:Controlled ProductApplications (4R,6S)-4H-Thieno[2,3-b]thiopyran-4-ol, 5,6-dihydro-6-methyl-,7,7-dioxide is an analog of topically-active carbonic anhydrase inhibitor MK-507 also commonly known as Dorzolamide (D535100).
References Blacklock, T., et al.: J. Org. Chem., 58, 1672 (1993); Tempkin, O., et al.: Tetrahedron: Asym., 7, 2721 (1996)Formula:C8H10O3S2Color and Shape:NeatMolecular weight:218.29Glimepiride-d4 (phenylethyl-a,a,b,b-d4) (cis/trans)
CAS:Controlled ProductApplications Glimepiride-d4 (phenylethyl-a,a,b,b-d4) (cis/trans) is a useful isotopically labeled compound of Glimepiride (G410150)
Formula:C24H30D4N4O5SColor and Shape:NeatMolecular weight:244.2Ibuprofen Alcohol
CAS:Controlled ProductApplications Ibuprofen Alcohol (Ibuprofen EP Impurity P) is an impurity of Ibuprofen (I140000). Ibuprofen impurity P as per EP.
References Haikala, V., et al.: J. Pharm. Sci., 80, 456 (1991), Zhao, J., et al.: Anal. Chem., 72, 302 (2000), Kucera, R., et al.: J. Pharm. Biomed. Anal., 38, 609 (2005),Formula:C13H20OColor and Shape:Colourless To Light YellowMolecular weight:192.38-Desethyl Etodolac
CAS:Controlled ProductImpurity Etodolac EP Impurity A
Applications 8-Desethyl Etodolac (Etodolac EP Impurity A) is an impurity of Etodolac (E933100) which was examined for mutagenicity in reverse mutation tests on bacteria. Etodolac impurity A.
References Franke, L., et al.: J. Med. Chem., 48, 6997 (2005), Fox, T., et al.: Curr. Top Med. Chem., 6, 1579 (2006),Formula:C15H17NO3Color and Shape:NeatMolecular weight:259.3Indomethacin 1-Glycerin Ester
CAS:Applications Indometacin 1-Glycerin Ester was synthesized and evaluated for anti-flammatory activity in the rate paw carrageenin edema essay.
References Paris, Gerard. , et al.: J. Med. Chem, 23, 9 (1980)Formula:C22H22ClNO6Color and Shape:NeatMolecular weight:431.87(S)-4-Hydroxy-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-Dioxide
CAS:Controlled ProductApplications (S)-4-Hydroxy-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-Dioxide has been used as a reactant for the preparation of Brinzolamide (AL-4862) [B677600], a topical carbonic anhydrase inhibitor.
References Conrow, R.E., et. al.: Org. Process Res. Dev., 3, 114 (1999)Formula:C10H16N2O6S3Color and Shape:NeatMolecular weight:356.444-Carboxy Tolbutamide-d9
CAS:Controlled ProductStability Hygroscopic
Applications A labelled metabolite of Tolbutamide. Formed by the cytochrome CYP2CIIC8 and IIC9 subfamily of P450 enzymes.
References Relling, etl al.: J. Pharmacol. Exp. Ther., 252, 442 (1990), Parent, et al.: J. Pharmacol. Exp. Ther., 261, 780 (1992), Ho, et al.: Life Sci., 52, 21 (1993),Formula:C12D9H7N2O5SColor and Shape:NeatMolecular weight:309.394-Nitro-2-phenoxyphenol
CAS:Applications 4-Nitro-2-phenoxyphenol is a impurity of Nimesulide (N477500), antiinflammatory agent. Preferentially inhibits COX-2 over COX-1. Suppresses chemical-induced carcinogenesis in mice and rats. Inhibits LPS-induced TNF-alpha production. Also used in the preparation of benzoxirenes and the synthesis of trioxonins.
References Pairet, M., et al.: Inflamm. Res., 47, S93 (1998), Fukutake, M., et al.: Carcinogenesis, 19, 1939 (1998), Okajima., E., et al.: Cancer Res., 58, 3028 (1998), Azab, A., et al.: Life Sci., 63, 323 (1998)Formula:C12H9NO4Color and Shape:Light YellowMolecular weight:231.2N-Nitroso Aceclofenac
Controlled ProductFormula:C16H12Cl2N2O5Color and Shape:NeatMolecular weight:383.183O-Desmethyl Indomethacin-d4
CAS:Controlled ProductApplications The major labelled metabolite of Indomethacin.
References Lewis, R., et al.: J. Clin. Invest., 53, 1607 (1974), Alvan, G., et al.: Clin. Pharmacol. Ther., 18, 364 (1975), Mungall, D., et al.: J. Pharm. Sci., 73, 1000 (1984), Baldwin, S., et al.: Xenobiotica, 25, 261 (1995),Formula:C18H10D4ClNO4Color and Shape:NeatMolecular weight:347.79Ibuprofen Dimer
CAS:Controlled ProductImpurity Ibuprofen EP Impurity G
Applications Ibuprofen Dimer (Ibuprofen EP Impurity G) is a dimer impurity of Ibuprofen (I140000).Formula:C26H32O4Color and Shape:Light Orange ColourMolecular weight:408.53Phenacetin-d3
CAS:Controlled ProductApplications Phenacetin-d3 is the labeled analogue of Phenacetin (P294580), an analgesic, antipyretic; component of APC tablets, analgesic mixture also containing aspirin and caffeine. Phenacetin is reasonably anticipated to be a human carcinogen; analgesic mixtures containing Phenacetin are listed as known human carcinogens.
References Boyd, et al.: Toxicol. Appl. Pharmacol., 1, 240 (1959); Dubach, C.U., et al.: N. Engl. J. Med., 308, 357 (1983)Formula:C10H10D3NO2Color and Shape:NeatMolecular weight:182.23
